0001209191-18-054612.txt : 20181010
0001209191-18-054612.hdr.sgml : 20181010
20181010085308
ACCESSION NUMBER: 0001209191-18-054612
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181008
FILED AS OF DATE: 20181010
DATE AS OF CHANGE: 20181010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hahn Mark W
CENTRAL INDEX KEY: 0001408502
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38135
FILM NUMBER: 181114939
MAIL ADDRESS:
STREET 1: 6340 QUADRANGLE DRIVE
STREET 2: SUITE 100
CITY: CHAPEL HILL
STATE: NC
ZIP: 27517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dova Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001685071
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813858961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 240 LEIGH FARM ROAD
CITY: DURHAM
STATE: NC
ZIP: 27707
BUSINESS PHONE: 919-806-4487
MAIL ADDRESS:
STREET 1: 240 LEIGH FARM ROAD
CITY: DURHAM
STATE: NC
ZIP: 27707
FORMER COMPANY:
FORMER CONFORMED NAME: Dova Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20160919
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-08
0
0001685071
Dova Pharmaceuticals Inc.
DOVA
0001408502
Hahn Mark W
C/O DOVA PHARMACEUTICALS, INC.
240 LEIGH FARM ROAD, SUITE 245
DURHAM
NC
27707
0
1
0
0
Chief Financial Officer
Employee Stock Option (Right to Buy)
20.42
2018-10-08
4
A
0
50000
0.00
A
2028-10-07
Common Stock
50000
50000
D
25% of the total shares subject to the option shall vest on October 8, 2019, and 1/48th of total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service with the Issuer as of each such date. The option allows for early exercise, subject to the Issuer's repurchase option, with respect to any unvested shares of Common Stock.
/s/ Mark Ballantyne, Attorney-in-Fact
2018-10-10